The corporates will invest the money in medical device technology companies graduating from the incubator over an eight-year period.
Israel-based drug producer Teva Pharmaceuticals and the healthcare arm of Netherlands-based technology company Royal Philips have launched a medical device technology incubator in Israel called Sanara Ventures, Globes has reported.
Philips and Teva have earmarked NIS 100m ($25m) in funding for the incubator’s graduates over the next eight years.
The incubator will fund and mentor startups in a variety of healthcare sectors ranging from digital health to continuum of care and disease management, diagnostics, sensing and monitoring, imaging, drug delivery…
